Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Mycophenolic acid
Drug ID BADD_D01508
Description Mycophenolic acid is an an immunosuppresant drug and potent anti-proliferative, and can be used in place of the older anti-proliferative azathioprine. It is usually used as part of triple therapy including a calcineurin inhibitor (ciclosporin or tacrolimus) and prednisolone. It is also useful in research for the selection of animal cells that express the E. coli gene coding for XGPRT (xanthine guanine phosphoribosyltransferase).
Indications and Usage For the prophylaxis of organ rejection in patients receiving allogeneic renal transplants, administered in combination with cyclosporine and corticosteroids.
Marketing Status approved
ATC Code L04AA06
DrugBank ID DB01024
KEGG ID D05096
MeSH ID D009173
PubChem ID 446541
TTD Drug ID D04FBR
NDC Product Code 72789-246; 68084-918; 70518-3218; 70748-218; 16729-189; 72789-247; 60505-2965; 67877-427; 70436-172; 0904-6785; 0078-0386; 16729-261; 70377-039; 0904-6786; 20076-0405; 50268-559; 60429-016; 60505-2966; 68084-907; 68254-5002; 50090-6492; 0378-4201; 52076-6215; 57885-0009; 60429-017; 67877-426; 70518-3255; 24979-161; 0378-4202; 70436-173; 70748-217; 65727-011; 0078-0385; 24979-160; 68254-5001; 70377-040; 51187-0004
UNII HU9DX48N0T
Synonyms Mycophenolic Acid | Mycophenolate Mofetil | Mofetil, Mycophenolate | Mycophenolic Acid Morpholinoethyl Ester | Cellcept | Mycophenolate Sodium | Sodium Mycophenolate | Mycophenolate, Sodium | Myfortic | Mycophenolate Mofetil Hydrochloride | Mofetil Hydrochloride, Mycophenolate | RS 61443 | RS-61443 | RS61443
Chemical Information
Molecular Formula C17H20O6
CAS Registry Number 24280-93-1
SMILES CC1=C2COC(=O)C2=C(C(=C1OC)CC=C(C)CCC(=O)O)O
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Venoocclusive liver disease12.02.09.039; 24.04.07.002; 09.01.06.0020.000951%
Venous pressure increased13.14.03.008--Not Available
Ventricular extrasystoles02.03.04.0070.000951%Not Available
Ventricular tachycardia02.03.04.010--
Vertigo17.02.12.002; 04.04.01.003--
Viral infection11.05.04.001--Not Available
Vision blurred17.17.01.010; 06.02.06.0070.001902%
Visual acuity reduced06.02.10.012; 17.17.01.0110.000951%
Visual field defect17.17.01.001; 06.02.07.003--Not Available
Visual impairment06.02.10.0130.009986%Not Available
Vomiting07.01.07.0030.011984%
Weight decreased13.15.01.005--
Weight increased13.15.01.006--
Wheezing22.03.01.009--
Wound infection12.01.08.012; 11.01.08.010--
Mobility decreased17.02.05.018; 08.01.03.030; 15.03.05.0230.001427%Not Available
Lymphocele24.09.02.002; 01.09.01.0080.001427%
Graft loss12.02.09.008--Not Available
Hypoacusis04.02.01.0060.006467%
Peripheral swelling08.01.03.053; 02.05.04.015--Not Available
Cytomegalovirus colitis07.19.01.007; 11.05.01.004--Not Available
Bladder spasm20.02.02.013--
Cytomegalovirus gastritis07.19.03.010; 11.05.01.008--Not Available
General physical health deterioration08.01.03.0180.001902%Not Available
Balance disorder08.01.03.081; 17.02.02.0070.000951%Not Available
Subileus07.13.01.004--Not Available
Contusion15.03.05.007; 24.07.06.001; 23.03.11.002; 12.01.06.001--
Nodular regenerative hyperplasia09.01.04.0040.000951%Not Available
Ear discomfort04.03.01.005--Not Available
Respiratory tract congestion22.02.07.003--Not Available
The 14th Page    First    Pre   14 15 16 17    Next   Last    Total 17 Pages
ADReCS-Target
Drug Name ADR Term Target
Tip:  Drug Name  ADR Term  Protein  Variation  Gene